Harmon

About the offering

Harmon DTC (operating as Harmon Retail Holdings Inc.) is a direct-to-consumer health and wellness roll-up platform conducting a Regulation CF offering at $0.50 per share, with a total raise target of $5 million at a $20 million valuation. The company is issuing Class B Common Stock (Non-Voting) through placement agent DealMaker Securities, LLC, with a minimum investment of $150. The company is built on the legacy of the Harmon brand, a 50-year-old health and beauty retailer with strong recognition in the NY/NJ metro area. Harmon DTC claims to own approximately 12 million customer data points and full trademark portfolios for both the Harmon brand and the Face Values private label beauty line, along with a website portfolio and multiple years of granular sales and SKU-level data. The core business strategy involves three interconnected components: (1) a GLP-1 and metabolic health telehealth offering built on a subscription model, enabling prescription GLP-1 medications (Semaglutide, Tirzepatide) and peptides through a managed patient journey from intake to ongoing subscription; (2) a shared operating infrastructure centralizing marketing, fulfillment, data, and regulatory functions across brands to lower costs and improve customer lifetime value; and (3) a DTC brand roll-up engine targeting undervalued post-2021 DTC brands for acquisition and integration into the shared platform stack. The company positions itself at the intersection of the $2 trillion U.S. health and wellness market, the rapidly growing GLP-1/metabolic health category, and a fragmented DTC brand landscape it views as ripe for consolidation. Management highlights lower customer acquisition costs (CAC) as a key competitive advantage due to owned first-party data and an existing customer base. The go-to-market plan is phased: Phase 1 focuses on launching the GLP-1 offering via digital acquisition, email/SMS campaigns, and the existing Harmon customer base; Phase 2 expands lifetime value through cross-selling supplements, beauty products, and continuity programs; Phase 3 scales the roll-up by acquiring and integrating additional DTC brands. The advisory board includes executives with 20–40+ years of experience across retail, beauty, CPG, and brand management, including former CMO of Burlington and Bed Bath (also a former McKinsey partner), former Chairman of Nautilus, and a longtime owner of National Wholesale Liquidators. Investor perks are tiered by both timing and investment amount. Early investors (Days 1–21) receive 10% bonus shares; Days 22–45 receive 5%. Volume-based perks begin at $500 and scale up to $50,000+, offering benefits such as free months of GLP-1 subscriptions, VIP memberships, beauty boxes, early product access, future round priority, and bonus share allocations of up to 20%. The offering is speculative and involves risks common to early-stage and startup equity crowdfunding investments, including illiquidity, no guaranteed returns, and the early-stage nature of the business model.

FAQ